Introduction: While rhBMP-2 is effective in promoting successful arthrodesis, many physicians avoid using it in anterior cervical spine fusions due to concern regarding an increased incidence of dysphagia, significant pre-vertebral swelling, and airway compromise. Pilot studies have shown that the local application of depomedrol may decrease the incidence of postoperative dysphagia. We carried out a prospective, randomized trial to evaluate the efficacy of local depomedrol application in reducing the severity of postoperative dysphagia following anterior cervical fusions using low-dose rhBMP-2. We hypothesize that locally administered depomedrol reduces dysphagia following these surgeries.
